Amedeo Smart

Free Medical Literature Service

 

Amedeo

Influenza
  Free Subscription

Articles published in
PLoS Med
    September 2022
  1. GRAM MA, Emborg HD, Schelde AB, Friis NU, et al
    Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study.
    PLoS Med. 2022;19:e1003992.
    >> Share

  2. FOFANA MO, Nery N Jr, Aguilar Ticona JP, de Andrade Belitardo EMM, et al
    Structural factors associated with SARS-CoV-2 infection risk in an urban slum setting in Salvador, Brazil: A cross-sectional survey.
    PLoS Med. 2022;19:e1004093.
    >> Share

    August 2022
  3. SAARINEN S, Moustgaard H, Remes H, Sallinen R, et al
    Income differences in COVID-19 incidence and severity in Finland among people with foreign and native background: A population-based cohort study of individuals nested within households.
    PLoS Med. 2022;19:e1004038.
    >> Share

  4. KIM S, Headley TY, Tozan Y
    Universal healthcare coverage and health service delivery before and during the COVID-19 pandemic: A difference-in-difference study of childhood immunization coverage from 195 countries.
    PLoS Med. 2022;19:e1004060.
    >> Share

  5. AHMED T, Roberton T, Vergeer P, Hansen PM, et al
    Healthcare utilization and maternal and child mortality during the COVID-19 pandemic in 18 low- and middle-income countries: An interrupted time-series analysis with mathematical modeling of administrative data.
    PLoS Med. 2022;19:e1004070.
    >> Share

  6. MODY A, Bradley C, Redkar S, Fox B, et al
    Quantifying inequities in COVID-19 vaccine distribution over time by social vulnerability, race and ethnicity, and location: A population-level analysis in St. Louis and Kansas City, Missouri.
    PLoS Med. 2022;19:e1004048.
    >> Share

  7. NIJMAN RG, Honeyford K, Farrugia R, Rose K, et al
    Presentations of children to emergency departments across Europe and the COVID-19 pandemic: A multinational observational study.
    PLoS Med. 2022;19:e1003974.
    >> Share

    July 2022
  8. REZEL-POTTS E, Douiri A, Sun X, Chowienczyk PJ, et al
    Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK.
    PLoS Med. 2022;19:e1004052.
    >> Share

  9. COBB NL, Collier S, Attia EF, Augusto O, et al
    Global influenza surveillance systems to detect the spread of influenza-negative influenza-like illness during the COVID-19 pandemic: Time series outlier analyses from 2015-2020.
    PLoS Med. 2022;19:e1004035.
    >> Share

  10. SHIBUYA K, Tan CC, Chun AY, Leung GM, et al
    Global human security in the post-COVID-19 era: The rising role of East Asia.
    PLoS Med. 2022;19:e1003939.
    >> Share

  11. HERNANDEZ I, Dickson S, Tang S, Gabriel N, et al
    Disparities in distribution of COVID-19 vaccines across US counties: A geographic information system-based cross-sectional study.
    PLoS Med. 2022;19:e1004069.
    >> Share

  12. MASSARI M, Spila Alegiani S, Morciano C, Spuri M, et al
    Postmarketing active surveillance of myocarditis and pericarditis following vaccination with COVID-19 mRNA vaccines in persons aged 12 to 39 years in Italy: A multi-database, self-controlled case series study.
    PLoS Med. 2022;19:e1004056.
    >> Share

    June 2022
  13. TAKUVA S, Takalani A, Seocharan I, Yende-Zuma N, et al
    Safety evaluation of the single-dose Ad26.COV2.S vaccine among healthcare workers in the Sisonke study in South Africa: A phase 3b implementation trial.
    PLoS Med. 2022;19:e1004024.
    >> Share

  14. WONG CKH, Lau KTK, Xiong X, Au ICH, et al
    Adverse events of special interest and mortality following vaccination with mRNA (BNT162b2) and inactivated (CoronaVac) SARS-CoV-2 vaccines in Hong Kong: A retrospective study.
    PLoS Med. 2022;19:e1004018.
    >> Share

  15. CUIJPERS P, Heim E, Abi Ramia J, Burchert S, et al
    Effects of a WHO-guided digital health intervention for depression in Syrian refugees in Lebanon: A randomized controlled trial.
    PLoS Med. 2022;19:e1004025.
    >> Share

  16. GRAIS RF, Baron E
    Addressing the impacts of COVID-19 on refugee health.
    PLoS Med. 2022;19:e1004050.
    >> Share

    May 2022
  17. MARTIN CA, Pan D, Melbourne C, Teece L, et al
    Risk factors associated with SARS-CoV-2 infection in a multiethnic cohort of United Kingdom healthcare workers (UK-REACH): A cross-sectional analysis.
    PLoS Med. 2022;19:e1004015.
    >> Share

  18. JIN P, Guo X, Chen W, Ma S, et al
    Safety and immunogenicity of heterologous boost immunization with an adenovirus type-5-vectored and protein-subunit-based COVID-19 vaccine (Convidecia/ZF2001): A randomized, observer-blinded, placebo-controlled trial.
    PLoS Med. 2022;19:e1003953.
    >> Share

  19. VAN GILS MJ, Lavell A, van der Straten K, Appelman B, et al
    Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines in health care workers in the Netherlands: A prospective cohort study.
    PLoS Med. 2022;19:e1003991.
    >> Share

  20. ALTARE C, Kostandova N, OKeeffe J, Hayek H, et al
    COVID-19 epidemiology and changes in health service utilization in Azraq and Zaatari refugee camps in Jordan: A retrospective cohort study.
    PLoS Med. 2022;19:e1003993.
    >> Share

  21. ANNWEILER C, Beaudenon M, Gautier J, Gonsard J, et al
    High-dose versus standard-dose vitamin D supplementation in older adults with COVID-19 (COVIT-TRIAL): A multicenter, open-label, randomized controlled superiority trial.
    PLoS Med. 2022;19:e1003999.
    >> Share

  22. BUITRAGO-GARCIA D, Ipekci AM, Heron L, Imeri H, et al
    Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: Update of a living systematic review and meta-analysis.
    PLoS Med. 2022;19:e1003987.
    >> Share

  23. MACHADO DB, Williamson E, Pescarini JM, Alves FJO, et al
    Relationship between the Bolsa Familia national cash transfer programme and suicide incidence in Brazil: A quasi-experimental study.
    PLoS Med. 2022;19:e1004000.
    >> Share

  24. BRUMMER LE, Katzenschlager S, McGrath S, Schmitz S, et al
    Accuracy of rapid point-of-care antigen-based diagnostics for SARS-CoV-2: An updated systematic review and meta-analysis with meta-regression analyzing influencing factors.
    PLoS Med. 2022;19:e1004011.
    >> Share

    April 2022
  25. FOO D, Sarna M, Pereira G, Moore HC, et al
    Prenatal influenza vaccination and allergic and autoimmune diseases in childhood: A longitudinal, population-based linked cohort study.
    PLoS Med. 2022;19:e1003963.
    >> Share

  26. WATKINSON RE, Williams R, Gillibrand S, Sanders C, et al
    Correction: Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in Greater Manchester, UK: A cohort study.
    PLoS Med. 2022;19:e1003982.
    >> Share

  27. WAINSTEIN M, MacDonald S, Fryer D, Young K, et al
    Use of an extended KDIGO definition to diagnose acute kidney injury in patients with COVID-19: A multinational study using the ISARIC-WHO clinical characterisation protocol.
    PLoS Med. 2022;19:e1003969.
    >> Share

    March 2022
  28. WATKINSON RE, Williams R, Gillibrand S, Sanders C, et al
    Ethnic inequalities in COVID-19 vaccine uptake and comparison to seasonal influenza vaccine uptake in Greater Manchester, UK: A cohort study.
    PLoS Med. 2022;19:e1003932.
    >> Share

  29. WANG C, Ong JJ, Zhao P, Weideman AM, et al
    Expanding syphilis test uptake using rapid dual self-testing for syphilis and HIV among men who have sex with men in China: A multiarm randomized controlled trial.
    PLoS Med. 2022;19:e1003930.
    >> Share

  30. MAURIN C, He Z, Mentek M, Verhoeven P, et al
    Exploration of the ocular surface infection by SARS-CoV-2 and implications for corneal donation: An ex vivo study.
    PLoS Med. 2022;19:e1003922.
    >> Share

  31. GIMMA A, Munday JD, Wong KLM, Coletti P, et al
    Changes in social contacts in England during the COVID-19 pandemic between March 2020 and March 2021 as measured by the CoMix survey: A repeated cross-sectional study.
    PLoS Med. 2022;19:e1003907.
    >> Share

    February 2022
  32. SAAKSVUORI L, Betsch C, Nohynek H, Salo H, et al
    Information nudges for influenza vaccination: Evidence from a large-scale cluster-randomized controlled trial in Finland.
    PLoS Med. 2022;19:e1003919.
    >> Share


  33. Vaccine equity: A fundamental imperative in the fight against COVID-19.
    PLoS Med. 2022;19:e1003948.
    >> Share

  34. KONTOPANTELIS E, Mamas MA, Webb RT, Castro A, et al
    Excess years of life lost to COVID-19 and other causes of death by sex, neighbourhood deprivation, and region in England and Wales during 2020: A registry-based study.
    PLoS Med. 2022;19:e1003904.
    >> Share

  35. CAUSEY K, Mosser JF
    Learning from the COVID-19 pandemic to strengthen routine immunization systems.
    PLoS Med. 2022;19:e1003934.
    >> Share

  36. MCQUAID F, Mulholland R, Sangpang Rai Y, Agrawal U, et al
    Uptake of infant and preschool immunisations in Scotland and England during the COVID-19 pandemic: An observational study of routinely collected data.
    PLoS Med. 2022;19:e1003916.
    >> Share

  37. KERR S, Joy M, Torabi F, Bedston S, et al
    First dose ChAdOx1 and BNT162b2 COVID-19 vaccinations and cerebral venous sinus thrombosis: A pooled self-controlled case series study of 11.6 million individuals in England, Scotland, and Wales.
    PLoS Med. 2022;19:e1003927.
    >> Share

    January 2022
  38. GENTILE I, Schiano Moriello N
    COVID-19 prophylaxis in immunosuppressed patients: Beyond vaccination.
    PLoS Med. 2022;19:e1003917.
    >> Share

  39. STRONGMAN H, Carreira H, De Stavola BL, Bhaskaran K, et al
    Factors associated with excess all-cause mortality in the first wave of the COVID-19 pandemic in the UK: A time series analysis using the Clinical Practice Research Datalink.
    PLoS Med. 2022;19:e1003870.
    >> Share

  40. BHASKARAN K, Rentsch CT, Hickman G, Hulme WJ, et al
    Overall and cause-specific hospitalisation and death after COVID-19 hospitalisation in England: A cohort study using linked primary care, secondary care, and death registration data in the OpenSAFELY platform.
    PLoS Med. 2022;19:e1003871.
    >> Share

  41. QUINN KL, Bell CM
    Pandemic health consequences: Grasping the long COVID tail.
    PLoS Med. 2022;19:e1003891.
    >> Share

  42. GUROL-URGANCI I, Waite L, Webster K, Jardine J, et al
    Obstetric interventions and pregnancy outcomes during the COVID-19 pandemic in England: A nationwide cohort study.
    PLoS Med. 2022;19:e1003884.
    >> Share

    December 2021
  43. GRAM MA, Nielsen J, Schelde AB, Nielsen KF, et al
    Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study.
    PLoS Med. 2021;18:e1003874.
    >> Share

  44. ABU-RADDAD LJ, Chemaitelly H, Ayoub HH, Coyle P, et al
    Introduction and expansion of the SARS-CoV-2 B.1.1.7 variant and reinfections in Qatar: A nationally representative cohort study.
    PLoS Med. 2021;18:e1003879.
    >> Share

  45. KARUNA S, Li SS, Grant S, Walsh SR, et al
    Neutralizing antibody responses over time in demographically and clinically diverse individuals recovered from SARS-CoV-2 infection in the United States and Peru: A cohort study.
    PLoS Med. 2021;18:e1003868.
    >> Share

  46. PETERSEN M, Schwab J, Havlir DV
    SARS-CoV-2 vaccine boosters: The time to act is now.
    PLoS Med. 2021;18:e1003882.
    >> Share

  47. MURHEKAR MV, Bhatnagar T, Thangaraj JWV, Saravanakumar V, et al
    Seroprevalence of IgG antibodies against SARS-CoV-2 among the general population and healthcare workers in India, June-July 2021: A population-based cross-sectional study.
    PLoS Med. 2021;18:e1003877.
    >> Share

  48. SENEFELD JW, Johnson PW, Kunze KL, Bloch EM, et al
    Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study.
    PLoS Med. 2021;18:e1003872.
    >> Share

    November 2021
  49. MARTIN CA, Marshall C, Patel P, Goss C, et al
    SARS-CoV-2 vaccine uptake in a multi-ethnic UK healthcare workforce: A cross-sectional study.
    PLoS Med. 2021;18:e1003823.
    >> Share

  50. BHANU C, Gopal DP, Walters K, Chaudhry UAR, et al
    Vaccination uptake amongst older adults from minority ethnic backgrounds: A systematic review.
    PLoS Med. 2021;18:e1003826.
    >> Share

  51. EPELBOIN S, Labrosse J, De Mouzon J, Fauque P, et al
    Obstetrical outcomes and maternal morbidities associated with COVID-19 in pregnant women in France: A national retrospective cohort study.
    PLoS Med. 2021;18:e1003857.
    >> Share

  52. ABDOOL KARIM SS, Kelemu S, Baxter C
    COVID-19 in Africa: Catalyzing change for sustainable development.
    PLoS Med. 2021;18:e1003869.
    >> Share

  53. SPLINTER MJ, Velek P, Ikram MK, Kieboom BCT, et al
    Prevalence and determinants of healthcare avoidance during the COVID-19 pandemic: A population-based cross-sectional study.
    PLoS Med. 2021;18:e1003854.
    >> Share

    October 2021
  54. STOVER J, Glaubius R, Teng Y, Kelly S, et al
    Modeling the epidemiological impact of the UNAIDS 2025 targets to end AIDS as a public health threat by 2030.
    PLoS Med. 2021;18:e1003831.
    >> Share

  55. PEARSON CAB, Bozzani F, Procter SR, Davies NG, et al
    COVID-19 vaccination in Sindh Province, Pakistan: A modelling study of health impact and cost-effectiveness.
    PLoS Med. 2021;18:e1003815.
    >> Share

  56. FORMICA N, Mallory R, Albert G, Robinson M, et al
    Different dose regimens of a SARS-CoV-2 recombinant spike protein vaccine (NVX-CoV2373) in younger and older adults: A phase 2 randomized placebo-controlled trial.
    PLoS Med. 2021;18:e1003769.
    >> Share

  57. BERGQVIST R, Ahlqvist VH, Lundberg M, Hergens MP, et al
    HMG-CoA reductase inhibitors and COVID-19 mortality in Stockholm, Sweden: A registry-based cohort study.
    PLoS Med. 2021;18:e1003820.
    >> Share

  58. GILBODY S, Littlewood E, McMillan D, Chew-Graham CA, et al
    Behavioural activation to prevent depression and loneliness among socially isolated older people with long-term conditions: The BASIL COVID-19 pilot randomised controlled trial.
    PLoS Med. 2021;18:e1003779.
    >> Share

  59. MO Y, Eyre DW, Lumley SF, Walker TM, et al
    Transmission of community- and hospital-acquired SARS-CoV-2 in hospital settings in the UK: A cohort study.
    PLoS Med. 2021;18:e1003816.
    >> Share

  60. IOANNOU GN, Ferguson JM, O'Hare AM, Bohnert ASB, et al
    Changes in the associations of race and rurality with SARS-CoV-2 infection, mortality, and case fatality in the United States from February 2020 to March 2021: A population-based cohort study.
    PLoS Med. 2021;18:e1003807.
    >> Share

  61. POLLETT S, Johansson MA, Reich NG, Brett-Major D, et al
    Recommended reporting items for epidemic forecasting and prediction research: The EPIFORGE 2020 guidelines.
    PLoS Med. 2021;18:e1003793.
    >> Share

  62. GENG EH, Reid MJA, Goosby E, Abdool-Karim Q, et al
    COVID-19 and global equity for health: The good, the bad, and the wicked.
    PLoS Med. 2021;18:e1003797.
    >> Share

    September 2021
  63. FIGUEROA JP, Hotez PJ, Batista C, Ben Amor Y, et al
    Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed.
    PLoS Med. 2021;18:e1003772.
    >> Share

  64. MUTHUKUMAR AV, Morrell W, Bierer BE
    Evaluating the frequency of English language requirements in clinical trial eligibility criteria: A systematic analysis using ClinicalTrials.gov.
    PLoS Med. 2021;18:e1003758.
    >> Share

  65. ELLIOTT J, Whitaker M, Bodinier B, Eales O, et al
    Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people.
    PLoS Med. 2021;18:e1003777.
    >> Share

  66. TAQUET M, Dercon Q, Luciano S, Geddes JR, et al
    Incidence, co-occurrence, and evolution of long-COVID features: A 6-month retrospective cohort study of 273,618 survivors of COVID-19.
    PLoS Med. 2021;18:e1003773.
    >> Share

  67. ADAM M, Johnston J, Job N, Dronavalli M, et al
    Evaluation of a community-based mobile video breastfeeding intervention in Khayelitsha, South Africa: The Philani MOVIE cluster-randomized controlled trial.
    PLoS Med. 2021;18:e1003744.
    >> Share

    August 2021
  68. BRUMMER LE, Katzenschlager S, Gaeddert M, Erdmann C, et al
    Accuracy of novel antigen rapid diagnostics for SARS-CoV-2: A living systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003735.
    >> Share

  69. KILMARX PH, Glass RI
    Building global health research capacity to address research imperatives following the COVID-19 pandemic.
    PLoS Med. 2021;18:e1003753.
    >> Share

    July 2021
  70. SULIS G, Batomen B, Kotwani A, Pai M, et al
    Sales of antibiotics and hydroxychloroquine in India during the COVID-19 epidemic: An interrupted time series analysis.
    PLoS Med. 2021;18:e1003682.
    >> Share

  71. IWANAMI S, Ejima K, Kim KS, Noshita K, et al
    Detection of significant antiviral drug effects on COVID-19 with reasonable sample sizes in randomized controlled trials: A modeling study.
    PLoS Med. 2021;18:e1003660.
    >> Share

  72. KANDULA S, Shaman J
    Investigating associations between COVID-19 mortality and population-level health and socioeconomic indicators in the United States: A modeling study.
    PLoS Med. 2021;18:e1003693.
    >> Share

    June 2021
  73. BUTLER-LAPORTE G, Nakanishi T, Mooser V, Morrison DR, et al
    Vitamin D and COVID-19 susceptibility and severity in the COVID-19 Host Genetics Initiative: A Mendelian randomization study.
    PLoS Med. 2021;18:e1003605.
    >> Share

  74. INZAULE SC, Ondoa P, Loembe MM, Tebeje YK, et al
    COVID-19 and indirect health implications in Africa: Impact, mitigation measures, and lessons learned for improved disease control.
    PLoS Med. 2021;18:e1003666.
    >> Share

  75. MAO W, Ogbuoji O, Watkins D, Bharali I, et al
    Achieving global mortality reduction targets and universal health coverage: The impact of COVID-19.
    PLoS Med. 2021;18:e1003675.
    >> Share

    May 2021
  76. GOLDMAN M, Hermans C
    Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity.
    PLoS Med. 2021;18:e1003648.
    >> Share

  77. STOKES AC, Lundberg DJ, Elo IT, Hempstead K, et al
    COVID-19 and excess mortality in the United States: A county-level analysis.
    PLoS Med. 2021;18:e1003571.
    >> Share

    April 2021
  78. KRISHNAN A, Dar L, Saha S, Narayan VV, et al
    Efficacy of live attenuated and inactivated influenza vaccines among children in rural India: A 2-year, randomized, triple-blind, placebo-controlled trial.
    PLoS Med. 2021;18:e1003609.
    >> Share

  79. ABIMBOLA S, Asthana S, Montenegro C, Guinto RR, et al
    Addressing power asymmetries in global health: Imperatives in the wake of the COVID-19 pandemic.
    PLoS Med. 2021;18:e1003604.
    >> Share

  80. GRANTZ KH, Lee EC, D'Agostino McGowan L, Lee KH, et al
    Maximizing and evaluating the impact of test-trace-isolate programs: A modeling study.
    PLoS Med. 2021;18:e1003585.
    >> Share

    March 2021
  81. LAFOND KE, Porter RM, Whaley MJ, Suizan Z, et al
    Global burden of influenza-associated lower respiratory tract infections and hospitalizations among adults: A systematic review and meta-analysis.
    PLoS Med. 2021;18:e1003550.
    >> Share

  82. BALCELLS ME, Rojas L, Le Corre N, Martinez-Valdebenito C, et al
    Early versus deferred anti-SARS-CoV-2 convalescent plasma in patients admitted for COVID-19: A randomized phase II clinical trial.
    PLoS Med. 2021;18:e1003415.
    >> Share

  83. REID M, Abdool-Karim Q, Geng E, Goosby E, et al
    How will COVID-19 transform global health post-pandemic? Defining research and investment opportunities and priorities.
    PLoS Med. 2021;18:e1003564.
    >> Share

  84. LEONG A, Cole JB, Brenner LN, Meigs JB, et al
    Cardiometabolic risk factors for COVID-19 susceptibility and severity: A Mendelian randomization analysis.
    PLoS Med. 2021;18:e1003553.
    >> Share

    January 2021
  85. SELIGMAN B, Ferranna M, Bloom DE
    Social determinants of mortality from COVID-19: A simulation study using NHANES.
    PLoS Med. 2021;18:e1003490.
    >> Share

    December 2020
  86. KIM MS, An MH, Kim WJ, Hwang TH, et al
    Comparative efficacy and safety of pharmacological interventions for the treatment of COVID-19: A systematic review and network meta-analysis.
    PLoS Med. 2020;17:e1003501.
    >> Share

    October 2020
  87. MAKARONIDIS J, Mok J, Balogun N, Magee CG, et al
    Seroprevalence of SARS-CoV-2 antibodies in people with an acute loss in their sense of smell and/or taste in a community-based population in London, UK: An observational cohort study.
    PLoS Med. 2020;17:e1003358.
    >> Share

  88. MCKEIGUE PM, Weir A, Bishop J, McGurnaghan SJ, et al
    Rapid Epidemiological Analysis of Comorbidities and Treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): A population-based case-control study.
    PLoS Med. 2020;17:e1003374.
    >> Share

  89. BASSETT MT, Chen JT, Krieger N
    Variation in racial/ethnic disparities in COVID-19 mortality by age in the United States: A cross-sectional study.
    PLoS Med. 2020;17:e1003402.
    >> Share

  90. KOLHE NV, Fluck RJ, Selby NM, Taal MW, et al
    Acute kidney injury associated with COVID-19: A retrospective cohort study.
    PLoS Med. 2020;17:e1003406.
    >> Share

    September 2020
  91. LUND LC, Kristensen KB, Reilev M, Christensen S, et al
    Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study.
    PLoS Med. 2020;17:e1003308.
    >> Share

  92. WHITE NJ, Watson JA, Hoglund RM, Chan XHS, et al
    COVID-19 prevention and treatment: A critical analysis of chloroquine and hydroxychloroquine clinical pharmacology.
    PLoS Med. 2020;17:e1003252.
    >> Share

  93. HARRISON SL, Fazio-Eynullayeva E, Lane DA, Underhill P, et al
    Comorbidities associated with mortality in 31,461 adults with COVID-19 in the United States: A federated electronic medical record analysis.
    PLoS Med. 2020;17:e1003321.
    >> Share

  94. BUITRAGO-GARCIA D, Egli-Gany D, Counotte MJ, Hossmann S, et al
    Occurrence and transmission potential of asymptomatic and presymptomatic SARS-CoV-2 infections: A living systematic review and meta-analysis.
    PLoS Med. 2020;17:e1003346.
    >> Share

  95. RENTSCH CT, Kidwai-Khan F, Tate JP, Park LS, et al
    Patterns of COVID-19 testing and mortality by race and ethnicity among United States veterans: A nationwide cohort study.
    PLoS Med. 2020;17:e1003379.
    >> Share

  96. JUUL S, Nielsen EE, Feinberg J, Siddiqui F, et al
    Interventions for treatment of COVID-19: A living systematic review with meta-analyses and trial sequential analyses (The LIVING Project).
    PLoS Med. 2020;17:e1003293.
    >> Share

  97. STOWE J, Andrews N, Gringras P, Quinnell T, et al
    Reassessment of the risk of narcolepsy in children in England 8 years after receipt of the AS03-adjuvanted H1N1 pandemic vaccine: A case-coverage study.
    PLoS Med. 2020;17:e1003225.
    >> Share

    August 2020
  98. BENJAMIN-CHUNG J, Arnold BF, Kennedy CJ, Mishra K, et al
    Evaluation of a city-wide school-located influenza vaccination program in Oakland, California, with respect to vaccination coverage, school absences, and laboratory-confirmed influenza: A matched cohort study.
    PLoS Med. 2020;17:e1003238.
    >> Share

  99. SIEDNER MJ, Harling G, Reynolds Z, Gilbert RF, et al
    Social distancing to slow the US COVID-19 epidemic: Longitudinal pretest-posttest comparison group study.
    PLoS Med. 2020;17:e1003244.
    >> Share

  100. HARRINGTON DM, O'Reilly M
    The reimagination of school-based physical activity research in the COVID-19 era.
    PLoS Med. 2020;17:e1003267.
    >> Share

    July 2020
  101. SAVICKAS V, Stewart AJ, Rees-Roberts M, Short V, et al
    Opportunistic screening for atrial fibrillation by clinical pharmacists in UK general practice during the influenza vaccination season: A cross-sectional feasibility study.
    PLoS Med. 2020;17:e1003197.
    >> Share

  102. TESLYA A, Pham TM, Godijk NG, Kretzschmar ME, et al
    Impact of self-imposed prevention measures and short-term government-imposed social distancing on mitigating and delaying a COVID-19 epidemic: A modelling study.
    PLoS Med. 2020;17:e1003166.
    >> Share

  103. PINOTTI F, Di Domenico L, Ortega E, Mancastroppa M, et al
    Tracing and analysis of 288 early SARS-CoV-2 infections outside China: A modeling study.
    PLoS Med. 2020;17:e1003193.
    >> Share

  104. WU YT, Liu J, Xu JJ, Chen YF, et al
    Neonatal outcome in 29 pregnant women with COVID-19: A retrospective study in Wuhan, China.
    PLoS Med. 2020;17:e1003195.
    >> Share

  105. HAUSER A, Counotte MJ, Margossian CC, Konstantinoudis G, et al
    Estimation of SARS-CoV-2 mortality during the early stages of an epidemic: A modeling study in Hubei, China, and six regions in Europe.
    PLoS Med. 2020;17:e1003189.
    >> Share

  106. ZHANG L, Tao Y, Shen M, Fairley CK, et al
    Can self-imposed prevention measures mitigate the COVID-19 epidemic?
    PLoS Med. 2020;17:e1003240.
    >> Share

  107. ADAMS J
    Addressing socioeconomic inequalities in obesity: Democratising access to resources for achieving and maintaining a healthy weight.
    PLoS Med. 2020;17:e1003243.
    >> Share

    June 2020
  108. TRUELOVE S, Abrahim O, Altare C, Lauer SA, et al
    The potential impact of COVID-19 in refugee camps in Bangladesh and beyond: A modeling study.
    PLoS Med. 2020;17:e1003144.
    >> Share

  109. ZHANG C, Gu J, Chen Q, Deng N, et al
    Clinical and epidemiological characteristics of pediatric SARS-CoV-2 infections in China: A multicenter case series.
    PLoS Med. 2020;17:e1003130.
    >> Share

  110. GREENHALGH T
    Will COVID-19 be evidence-based medicine's nemesis?
    PLoS Med. 2020;17:e1003266.
    >> Share

    May 2020
  111. KAZATCHKINE MD, Goldman M, Vincent JL
    Antibody-based therapies for COVID-19: Can Europe move faster?
    PLoS Med. 2020;17:e1003127.
    >> Share


  112. Pandemic preparedness and responses: WHO to turn to in a crisis?
    PLoS Med. 2020;17:e1003167.
    >> Share

    April 2020

  113. Pandemic responses: Planning to neutralize SARS-CoV-2 and prepare for future outbreaks.
    PLoS Med. 2020;17:e1003123.
    >> Share

    March 2020
  114. FORSTER AH, Witham K, Depelsenaire ACI, Veitch M, et al
    Safety, tolerability, and immunogenicity of influenza vaccination with a high-density microarray patch: Results from a randomized, controlled phase I clinical trial.
    PLoS Med. 2020;17:e1003024.
    >> Share

    January 2020
  115. SHEARER FM, Moss R, McVernon J, Ross JV, et al
    Infectious disease pandemic planning and response: Incorporating decision analysis.
    PLoS Med. 2020;17:e1003018.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016